bufalin and betadex

bufalin has been researched along with betadex in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Che, X; Liu, Y; Ma, Y; Qu, X; Teng, Y; Xu, L; Yan, S; Zhang, L; Zou, H1
Garamus, VM; Handge, UA; Willumeit-Römer, R; Yin, P; Zhao, X; Zou, A1

Other Studies

2 other study(ies) available for bufalin and betadex

ArticleYear
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
    Anti-cancer drugs, 2014, Volume: 25, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cholesterol; Female; Humans; Membrane Microdomains; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand

2014
Folate receptor targeted bufalin/β-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin.
    Materials science & engineering. C, Materials for biological applications, 2017, Sep-01, Volume: 78

    Topics: Antineoplastic Agents; beta-Cyclodextrins; Bufanolides; Calorimetry, Differential Scanning; Folic Acid; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2017